Next Generation Ophthalmic Irrigating Solution Posterior Segment Study

• Status: Completed
• Trial end date: 2006-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS PLUS for use during surgery for removal of epimacular membrane and vitrectomy.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Patients of any race and sex, with an epimacular membrane who would benefit from vitrectomy and membrane removal.

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Under 18 years of age.

• Other protocol-defined exclusion criteria may apply.